First Ray received FDA 510(k) clearance for Stealth Staple™, an intraosseous small bone fixation system for the treatment of arthrodesis, osteotomies and bone fractures.
Stealth Staple is completely contained within bone, offering the potential to substantially reduce clinical complications related to prominent hardware associated with current standard-of-care devices used to treat these indications. These complications may lead to pain, soft tissue irritation and hardware removal.
First Ray is a development stage device company incubated and operated by Surgical Frontiers, whose portfolio also includes KATOR.
First Ray received FDA 510(k) clearance for Stealth Staple™, an intraosseous small bone fixation system for the treatment of arthrodesis, osteotomies and bone fractures.
Stealth Staple is completely contained within bone, offering the potential to substantially reduce clinical complications related to prominent hardware associated with...
First Ray received FDA 510(k) clearance for Stealth Staple™, an intraosseous small bone fixation system for the treatment of arthrodesis, osteotomies and bone fractures.
Stealth Staple is completely contained within bone, offering the potential to substantially reduce clinical complications related to prominent hardware associated with current standard-of-care devices used to treat these indications. These complications may lead to pain, soft tissue irritation and hardware removal.
First Ray is a development stage device company incubated and operated by Surgical Frontiers, whose portfolio also includes KATOR.
Copy to clipboard 
